Gene · 309
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity. | Cancer Res | 2022 | 35131870 | PubTator, text mining | PubMed |
| Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity. | RSC Chem Biol | 2022 | 35128413 | PubTator, text mining | PubMed |
| Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors. | ACS Omega | 2022 | 35128241 | PubTator, text mining | PubMed |
| Matrix Vesicles as a Therapeutic Target for Vascular Calcification. | Front Cell Dev Biol | 2022 | 35127686 | PubTator, text mining | PubMed |
| Matrisome changes in Parkinson's disease. | Anal Bioanal Chem | 2022 | 35112150 | PubTator, text mining | PubMed |
| Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis. | J Exp Clin Cancer Res | 2022 | 35105345 | PubTator, text mining | PubMed |
| LRG1: an emerging player in disease pathogenesis. | J Biomed Sci | 2022 | 35062948 | PubTator, text mining | PubMed |
| Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses. | Viruses | 2022 | 35062328 | PubTator, text mining | PubMed |
| Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. | J Nanobiotechnology | 2022 | 35057811 | PubTator, text mining | PubMed |
| Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease. | Am J Respir Crit Care Med | 2022 | 35044899 | PubTator, text mining | PubMed |
| Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1. | Genome Med | 2022 | 35042540 | PubTator, text mining | PubMed |
| Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. | Cell Commun Signal | 2022 | 35033111 | PubTator, text mining | PubMed |
| Annexin A6 and NPC1 regulate LDL-inducible cell migration and distribution of focal adhesions. | Sci Rep | 2022 | 35022465 | PubTator, text mining | PubMed |
| N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer. | Int J Oncol | 2022 | 35014676 | PubTator, text mining | PubMed |
| Transgenerational effects on the fecundity and sperm proteome in rats exposed to a mixture of pyrethroids at doses similar to human consumption. | Chemosphere | 2022 | 34896426 | PubTator, text mining | PubMed |
| Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. | Prostate Cancer Prostatic Dis | 2022 | 34815548 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. | Cancer Med | 2022 | 34791836 | PubTator, text mining | PubMed |
| Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. | Nat Med | 2022 | 34782790 | PubTator, text mining | PubMed |
| Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy. | Adv Sci (Weinh) | 2022 | 34747157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/309/papers?page=21